世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
ウイルスフィルター市場。世界の産業動向、シェア、サイズ、成長、機会、および2021-2026年の予測Virus Filtration Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 The global virus filtration market grew at a CAGR of around 11% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit strong growth during 2021-2026. Keeping in mind the unce... もっと見る
サマリーThe global virus filtration market grew at a CAGR of around 11% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit strong growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.Virus filtration is an effective, non-destructive, and easy to use method of retaining both enveloped and non-enveloped virus particles on the surface or within the pores of a polymeric membrane. It finds extensive applications in continuous bioprocessing, which is gaining traction in monoclonal antibodies (MAbs) for providing small facility footprints. As it does not impact the product quality, it is considered an ideal solution for manufacturing biological products, such as vaccines, somatic cells, gene therapy, and recombinant therapeutic proteins, and enhancing their safety. It is also used to remove blood-borne pathogens from plasma-derived products. The urgent need for potential therapies and vaccines to treat coronavirus disease (COVID-19) patients under critical conditions is promoting the application of virus filtration in the convalescent plasma for reducing inflammatory mediators. Moreover, advancements in bioprocessing technologies, including single-use equipment, perfusion reactors, and chromatography resins, are positively influencing the adoption of virus filtration in the manufacturing of various biotherapeutic products. The increasing demand for these products can be associated with the significant rise in the prevalence of chronic diseases worldwide. Additionally, regulatory agencies of numerous countries have mandated virus control at various stages of the drug manufacturing process to ensure the virological safety of biological therapeutics, which is also contributing to the market growth. Apart from this, the introduction of an advanced asymmetric membrane structure that provides no impact on virus retention through pressure variations, high loads, or process interruptions is anticipated to stimulate the market growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global virus filtration market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, application and end use. Breakup by Product: Consumables Kits and Reagents Others Instruments Filtration Systems Chromatography Systems Services Breakup by Application: Biologicals Vaccines and Therapeutics Blood and Blood Products Cellular and Gene Therapy Products Others Medical Devices Water Purification Air Purification Others Breakup by End Use: Biopharmaceutical and Biotechnology Companies Contract Research Organizations Academic Institutes and Research Laboratories Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Medical Co. Ltd., Charles River Laboratories, Inc., Clean Cells, Danaher Corporation, Merck KGaA, Sartorius AG and Thermo Fisher Scientific Inc. Key Questions Answered in This Report: How has the global virus filtration market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global virus filtration market? What are the key regional markets? What is the breakup of the market based on the product? What is the breakup of the market based on the application? What is the breakup of the market based on the end use? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global virus filtration market and who are the key players? What is the degree of competition in the industry? 目次1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Virus Filtration Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product 6.1 Consumables 6.1.1 Market Trends 6.1.2 Major Types 6.1.2.1 Kits and Reagents 6.1.2.2 Others 6.1.3 Market Forecast 6.2 Instruments 6.2.1 Market Trends 6.2.2 Major Types 6.2.2.1 Filtration Systems 6.2.2.2 Chromatography Systems 6.2.3 Market Forecast 6.3 Services 6.3.1 Market Trends 6.3.2 Market Forecast 7 Market Breakup by Application 7.1 Biologicals 7.1.1 Market Trends 7.1.2 Major Types 7.1.2.1 Vaccines and Therapeutics 7.1.2.2 Blood and Blood Products 7.1.2.3 Cellular and Gene Therapy Products 7.1.2.4 Others 7.1.3 Market Forecast 7.2 Medical Devices 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Water Purification 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Air Purification 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Others 7.5.1 Market Trends 7.5.2 Market Forecast 8 Market Breakup by End Use 8.1 Biopharmaceuticals and Biotechnology Companies 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Contract Research Organizations 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Academic Institutes and Research Laboratories 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Others 8.4.1 Market Trends 8.4.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 United States 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Canada 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.2 Asia-Pacific 9.2.1 China 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Japan 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 India 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 South Korea 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.2.5 Australia 9.2.5.1 Market Trends 9.2.5.2 Market Forecast 9.2.6 Indonesia 9.2.6.1 Market Trends 9.2.6.2 Market Forecast 9.2.7 Others 9.2.7.1 Market Trends 9.2.7.2 Market Forecast 9.3 Europe 9.3.1 Germany 9.3.1.1 Market Trends 9.3.1.2 Market Forecast 9.3.2 France 9.3.2.1 Market Trends 9.3.2.2 Market Forecast 9.3.3 United Kingdom 9.3.3.1 Market Trends 9.3.3.2 Market Forecast 9.3.4 Italy 9.3.4.1 Market Trends 9.3.4.2 Market Forecast 9.3.5 Spain 9.3.5.1 Market Trends 9.3.5.2 Market Forecast 9.3.6 Russia 9.3.6.1 Market Trends 9.3.6.2 Market Forecast 9.3.7 Others 9.3.7.1 Market Trends 9.3.7.2 Market Forecast 9.4 Latin America 9.4.1 Brazil 9.4.1.1 Market Trends 9.4.1.2 Market Forecast 9.4.2 Mexico 9.4.2.1 Market Trends 9.4.2.2 Market Forecast 9.4.3 Others 9.4.3.1 Market Trends 9.4.3.2 Market Forecast 9.5 Middle East and Africa 9.5.1 Market Trends 9.5.2 Market Breakup by Country 9.5.3 Market Forecast 10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Asahi Kasei Medical Co. Ltd. 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.2 Charles River Laboratories Inc. 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.2.3 Financials 14.3.2.4 SWOT Analysis 14.3.3 Clean Cells 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.3.3 Financials 14.3.4 Danaher Corporation 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.4.4 SWOT Analysis 14.3.5 Merck KGaA 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.6 Sartorius AG 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.6.3 Financials 14.3.6.4 SWOT Analysis 14.3.7 Thermo Fisher Scientific Inc. 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.7.3 Financials 14.3.7.4 SWOT Analysis
SummaryThe global virus filtration market grew at a CAGR of around 11% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit strong growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.Virus filtration is an effective, non-destructive, and easy to use method of retaining both enveloped and non-enveloped virus particles on the surface or within the pores of a polymeric membrane. It finds extensive applications in continuous bioprocessing, which is gaining traction in monoclonal antibodies (MAbs) for providing small facility footprints. As it does not impact the product quality, it is considered an ideal solution for manufacturing biological products, such as vaccines, somatic cells, gene therapy, and recombinant therapeutic proteins, and enhancing their safety. It is also used to remove blood-borne pathogens from plasma-derived products. The urgent need for potential therapies and vaccines to treat coronavirus disease (COVID-19) patients under critical conditions is promoting the application of virus filtration in the convalescent plasma for reducing inflammatory mediators. Moreover, advancements in bioprocessing technologies, including single-use equipment, perfusion reactors, and chromatography resins, are positively influencing the adoption of virus filtration in the manufacturing of various biotherapeutic products. The increasing demand for these products can be associated with the significant rise in the prevalence of chronic diseases worldwide. Additionally, regulatory agencies of numerous countries have mandated virus control at various stages of the drug manufacturing process to ensure the virological safety of biological therapeutics, which is also contributing to the market growth. Apart from this, the introduction of an advanced asymmetric membrane structure that provides no impact on virus retention through pressure variations, high loads, or process interruptions is anticipated to stimulate the market growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global virus filtration market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, application and end use. Breakup by Product: Consumables Kits and Reagents Others Instruments Filtration Systems Chromatography Systems Services Breakup by Application: Biologicals Vaccines and Therapeutics Blood and Blood Products Cellular and Gene Therapy Products Others Medical Devices Water Purification Air Purification Others Breakup by End Use: Biopharmaceutical and Biotechnology Companies Contract Research Organizations Academic Institutes and Research Laboratories Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Medical Co. Ltd., Charles River Laboratories, Inc., Clean Cells, Danaher Corporation, Merck KGaA, Sartorius AG and Thermo Fisher Scientific Inc. Key Questions Answered in This Report: How has the global virus filtration market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global virus filtration market? What are the key regional markets? What is the breakup of the market based on the product? What is the breakup of the market based on the application? What is the breakup of the market based on the end use? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global virus filtration market and who are the key players? What is the degree of competition in the industry? Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Virus Filtration Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product 6.1 Consumables 6.1.1 Market Trends 6.1.2 Major Types 6.1.2.1 Kits and Reagents 6.1.2.2 Others 6.1.3 Market Forecast 6.2 Instruments 6.2.1 Market Trends 6.2.2 Major Types 6.2.2.1 Filtration Systems 6.2.2.2 Chromatography Systems 6.2.3 Market Forecast 6.3 Services 6.3.1 Market Trends 6.3.2 Market Forecast 7 Market Breakup by Application 7.1 Biologicals 7.1.1 Market Trends 7.1.2 Major Types 7.1.2.1 Vaccines and Therapeutics 7.1.2.2 Blood and Blood Products 7.1.2.3 Cellular and Gene Therapy Products 7.1.2.4 Others 7.1.3 Market Forecast 7.2 Medical Devices 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Water Purification 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Air Purification 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Others 7.5.1 Market Trends 7.5.2 Market Forecast 8 Market Breakup by End Use 8.1 Biopharmaceuticals and Biotechnology Companies 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Contract Research Organizations 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Academic Institutes and Research Laboratories 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Others 8.4.1 Market Trends 8.4.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 United States 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Canada 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.2 Asia-Pacific 9.2.1 China 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Japan 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 India 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 South Korea 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.2.5 Australia 9.2.5.1 Market Trends 9.2.5.2 Market Forecast 9.2.6 Indonesia 9.2.6.1 Market Trends 9.2.6.2 Market Forecast 9.2.7 Others 9.2.7.1 Market Trends 9.2.7.2 Market Forecast 9.3 Europe 9.3.1 Germany 9.3.1.1 Market Trends 9.3.1.2 Market Forecast 9.3.2 France 9.3.2.1 Market Trends 9.3.2.2 Market Forecast 9.3.3 United Kingdom 9.3.3.1 Market Trends 9.3.3.2 Market Forecast 9.3.4 Italy 9.3.4.1 Market Trends 9.3.4.2 Market Forecast 9.3.5 Spain 9.3.5.1 Market Trends 9.3.5.2 Market Forecast 9.3.6 Russia 9.3.6.1 Market Trends 9.3.6.2 Market Forecast 9.3.7 Others 9.3.7.1 Market Trends 9.3.7.2 Market Forecast 9.4 Latin America 9.4.1 Brazil 9.4.1.1 Market Trends 9.4.1.2 Market Forecast 9.4.2 Mexico 9.4.2.1 Market Trends 9.4.2.2 Market Forecast 9.4.3 Others 9.4.3.1 Market Trends 9.4.3.2 Market Forecast 9.5 Middle East and Africa 9.5.1 Market Trends 9.5.2 Market Breakup by Country 9.5.3 Market Forecast 10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Asahi Kasei Medical Co. Ltd. 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.2 Charles River Laboratories Inc. 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.2.3 Financials 14.3.2.4 SWOT Analysis 14.3.3 Clean Cells 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.3.3 Financials 14.3.4 Danaher Corporation 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.4.4 SWOT Analysis 14.3.5 Merck KGaA 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.6 Sartorius AG 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.6.3 Financials 14.3.6.4 SWOT Analysis 14.3.7 Thermo Fisher Scientific Inc. 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.7.3 Financials 14.3.7.4 SWOT Analysis
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（消費財）の最新刊レポート
IMARC Services Private Limited.社のその他分野での最新刊レポート
本レポートと同じKEY WORD（virus）の最新刊レポートよくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/13 10:29 155.97 円 166.03 円 201.39 円 |
